Why should you add proteomics to your current genomics research program?

Being able to profile 1000’s of proteins from just a few µL of sample and identifying genetic associations provides the vital link to combine proteomics to genomics and link genotype to phenotype.

This detailed white paper describes how the integration of genomics and proteomics data heralds a new era of discovery. Data from the landmark UK Biobank – Pharma Proteomics Project, as well as the SCALLOP consortium, have identified many new associations between genetic variants and circulating protein levels. These associations, or protein Quantitative Trait Loci (pQTLs), help link genotype to phenotype and are the key to finding proteins that cause disease and advance our understanding of human biology.

Learn how proteomics helps: 

• Reveal proteins and pathways likely to be causal in disease from GWAS data
• Drive reclassification of diseases and understand the mechanisms of disease pathophysiology
• Identify novel disease biomarkers and new drug targets leading to more effective medicines
• Bridge the gap between genetics and disease pathology and provide a more comprehensive understanding of human biology

Download your free white paper “Empower Genomics with Proteomics" today.